Tuesday
28Apr2009

Combined ID/CC Grand Round May 7th 2009

THIS MEETING HAS BEEN CANCELLED

PRESENTERs: Dr. Walter Schlech, Infection Diseases &
Dr. Rob Green, Critical & Emergency Care Medicine

TOPIC: Evidence based sepsis protocol for the QEII

Objectives:

1. To review the evidence based sepsis protocol developed for the QEII
2. To use the protocol for a hands on septic case
3. To obtain feedback on the sepsis protocol

Monday
23Feb2009

Grand Rounds March 5th 2009: Dr. R. Green

@ 12:00 - 13:00 in Bethune 378

Post-intubation Hemodynamic Instability - "I got the airway….but the patient died."

Dr. Robert S. Green, BSc, MD, DABEM, FRCPC
Associate Professor
Critical Care & Emergency Medicine

Objectives:
1. To describe the differences in emergent vs. non-emergent endotracheal intubation
2. To present the results of a systematic review on PIHI
3. To present local data on emergent EETI
4. To present the PIHI Research Program

Saturday
10Jan2009

Grand Rounds January 15th 2009: Dr. J. Hancock

@12:00 – 1:00 PM in Bethune 378

It’s April and Your Patient has Acute Renal Failure… Now What?

by Dr. Jennifer Hancock, BSc, MD, FRCPC, CCM
Assistant Professor, General Internal Medicine & Critical Care 

View more presentations from fergua.
Friday
31Oct2008

Grand Rounds November 13th 2008: Dr. A. Ferguson

@12:00 – 1:00 PM in Bethune 379

Echinocandins in the ICU: Do we really need them (yet)?

by Dr. Andrew Ferguson, MEd, FRCA, FCARCSI, DIBICM, FCCP

Assistant Professor of Medicine (Critical Care) and Anesthesia, Dalhousie University
& Consultant in Anaesthesia and Intensive Care Medicine, Craigavon Area Hospital, United Kingdom 

Objectives: At the end of this presentation you will be able to:

  • Describe the mechanisms by which “antifungal” agents work
  • List the mechanisms of resistance to antifungal agents and the most common resistance profiles for  Candida and Aspergillus species
  • Describe the limitations of research evidence into antifungal therapy in ICU
  • Discuss the potential limitations of current first-line agents
  • List the drug interaction and side-effect profiles of current agents
  • Describe the pharmacological and therapeutic benefits of echinocandins
  • Discuss where echincandin agents might fit into the therapeutic approach  
View SlideShare presentation or Upload your own. (tags: intensive antifungal)
Wednesday
13Aug2008

Grand Rounds September 4th 2008: Dr. Sarah McMullen

Are we surviving sepsis? Experience from a quality assurance project at a tertiary care teaching hospital

Sarah M. McMullen, MD, BSc, MS, Critical Care sub-specialty trainee

Objectives:

  1. To review the pathophysiology of sepsis/septic shock
  2. To review the evidence for treatment algorithms in severe sepsis/septic shock, including early goal-directed therapy, early antibiotics, role of steroids
  3. To understand possible limitations in the recognition, and therefore the treatment of, sepsis/septic shock

 

Wednesday
21May2008

Grand Rounds June 2nd 2008 - Dr. T. Topp Abdominal Compartment Syndrome

Room 378 Bethune Building, VG Site at 12:00 - 1:00 PM

Abdominal Compartment Syndrome

By

Trevor J. Topp, MD, FRCSC, FACS

Head, Division of General Surgery, QEII HSC
Assistant Professor of Medicine and Surgery, Dalhousie University General Surgery and Critical Care Medicine

Objectives:

  1. To obtain an understanding of the diagnosis and treatment principles of abdominal compartment syndrome
  2. To become familiar with techniques of management of the open abdomen
  3. To understand the role of the Critical Care Unit in preparing the patient for surgical closure of the open abdomen

Why not also review our Synopsis on Abdominal Compartment Syndrome? 

"This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certifications program of The Royal College of
Physicians and Surgeons of Canada, approved by Critical Care Medicine Grand Rounds."

ICU Residents & Clerks Please note attendance at Critical Care Grand Rounds is mandatory. Lunch is provided by unrestricted grant from Wyeth Pharmaceuticals.

Wednesday
23Apr2008

Grand Rounds May 12th 2008 - Dr. J. Boldt Crystalloids or Colloids in the ICU

Room 38 Basement Bethune Building, VG Site at 12:00 – 1:00 PM

New Advances in Fluid Management of the Critically Ill Patient: Crystalloids or Colloids in the ICU?

By Professor Joachim Boldt, Head of the Department of Anesthesiology and Intensive Care Medicine
Klinikum Ludwigshafen
, Germany

Objectives:

  • To increase current knowledge of fluid therapy practices globally and to improve practice skill in fluid therapy management for ICU patients
  • To expand their knowledge with respect to the differences between colloid plasma volume expansion agents
  • To better understand the pharmacology of artificial colloids


Monday
07Apr2008

Grand Rounds April 7th 2008: Post-Extubation Stridor Dr. J. Chisholm

Dr. J. Chisholm Presenting
Miller RL, Cole RP. Chest. 1996 Oct;110(4):1035-40. Association between reduced cuff leak volume and postextubation stridor. STUDY OBJECTIVE: Laryngotracheal injury or edema in the setting of intubation may narrow the upper airway and predispose toward postextubation stridor. The presence or absence of an audible airleak when the sealing balloon cuff of the endotracheal tube is deflated has been demonstrated to be a marker of laryngotracheal edema in high-risk patients. We hypothesized that (1) the volume of the cuff leak can be quantified in a general medical ICU population, and (2) the cuff leak volume can be correlated with likelihood of postextubation stridor. METHODS: Within 24 h of both the initiation and termination of mechanical ventilation, the cuff leak volume, defined as the difference between the inspiratory tidal volume and the averaged expiratory tidal volume while the cuff around the endotracheal tube was deflated, was recorded. RESULTS: In 100 consecutive intubations, the preextubation cuff leak volume was 349 +/- 163 mL [mean +/- SD]). Overall, 6% of extubations were accompanied by postextubation stridor. The mean cuff leak volume measured within 24 h of planned extubation was significantly lower in those who subsequently developed stridor in comparison to those who did not (180 +/- 157 mL vs 360 +/- 157 mL; p = 0.012). The positive predictive value for postextubation stridor in the setting of a cuff leak less than 110 mL was 0.80, the predictive value for absence of postextubation stridor with a cuff leak volume greater than 110 mL was 0.98, and the specificity of the test was 0.99. No other demographic factors or indexes related to mechanical ventilation were significantly different between the two groups. CONCLUSIONS: A reduced cuff leak volume prior to extubation identifies a population at increased risk for postextubation stridor.

Jaber S, Chanques G, Matecki S, et al. Intensive Care Med. 2003 Jan;29(1):69-74.Post-extubation stridor in intensive care unit patients. Risk factors evaluation and importance of the cuff-leak test. OBJECTIVE: To evaluate the incidence and identify factors associated with the occurrence of post-extubation stridor and to evaluate the performance of the cuff-leak test in detecting this complication. DESIGN: Prospective, clinical investigation. SETTING: Intensive care unit of a university hospital. PATIENTS: Hundred twelve extubations were analyzed in 112 patients during a 14-month period. INTERVENTION: A cuff-leak test before each extubation. MEASUREMENTS AND RESULTS: The incidence of stridor was 12%. When we chose the thresholds of 130 ml and 12% to quantify the cuff-leak volume, the sensitivity and the specificity of the test were, respectively, 85% and 95%. The patients who developed stridor had a cuff leak significantly lower than the others, expressed in absolute values (372+/-170 vs 59+/-92 ml, p<0.001) or in relative values (56+/-20 vs 9+/-13%, p<0.001). Stridor was associated with an elevated Simplified Acute Physiology Score (SAPS II), a medical reason for admission, a traumatic or difficult intubation, a history of self-extubation, an over-inflated balloon cuff at admission to ICU and a prolonged period of intubation. These results provide a framework with which to identify patients at risk of developing a stridor after extubation. CONCLUSION: A low cuff-leak volume (<130 ml or 12%) around the endotracheal tube prior to extubation is useful in identifying patients at risk for post-extubation stridor.

Maury E, Guglielminotti J, Alzieu M, et al. J Crit Care. 2004 Mar;19(1):23-8.How to identify patients with no risk for postextubation stridor? The aim of this study was first, to evaluate the value of cough following tracheal tube cuff deflation, and second, to reassess the value of the cuff-leak test to predict postextubation stridor (PES). In spontaneously breathing patients, immediately before extubation, the tracheal tube was deflated and the absence of cough was monitored. The tube was then obstructed with a finger, and the absence of leak was monitored. Extubation was then performed. Four PESs were observed after 115 extubations (incidence: 3.5%). The absence of cough was more frequently observed when PES occurred than when it did not (75% v 21%, P =.04). The absence of leak was observed in 100% of PES and in 20% of PES free extubations (P =.01). The absence of both leak and cough was more frequently observed in PES (75% v 7%, P <.0001). In the absence of leak, the likelihood ratio of developing PES was 5.04 and rose to 10.4 when cough was also absent. The likelihood ratio of not developing PES in the absence of leak alone was 0. We conclude that in a population of medical intensive care unit spontaneously breathing patients, just before extubation, the presence of leaking around the endotracheal tube rules out PES, whereas the absence of cough and of leak are good predictors of PES.

Cheng KC, Hou CC, Huang HC, Lin SC, Zhang H.Crit Care Med. 2006 May;34(5):1345-50.Intravenous injection of methylprednisolone reduces the incidence of postextubation stridor in intensive care unit patients. OBJECTIVE: To determine whether treatment with corticosteroids decreases the incidence of postextubation airway obstruction in an adult intensive care unit. DESIGN: Clinical experiment. SETTING: Adult medical and surgical intensive care unit of a teaching hospital. PATIENTS: One hundred twenty-eight patients who were intubated for >24 hrs with a cuff leak volume <24% of tidal volume and met weaning criteria. INTERVENTIONS: Patients were randomized into a placebo group (control, n = 43) receiving four injections of normal saline every 6 hrs, a 4INJ group (n = 42) receiving four injections of methylprednisolone sodium succinate, or a 1INJ group (n = 42) receiving one injection of the corticosteroid followed by three injections of normal saline. Cuff volume was assessed 1 hr after each injection, and extubation was performed 1 hr after the last injection. Postextubation stridor was confirmed by examination using bronchoscopy or laryngoscopy. MEASUREMENTS AND MAIN RESULTS: The incidences of postextubation stridor were lower both in the 1INJ and the 4INJ groups than in the control group (11.6% and 7.1% vs. 30.2%, both p < .05), whereas there was no difference between the two treated groups (p = .46). The cuff leak volume increased after the second and fourth injection in the 4INJ group and after a second injection in the 1INJ group compared with the control group (both p < .05). CONCLUSIONS: A reduced cuff leak volume is a reliable indicator to identify patients at high risk to develop stridor. Treatment with a single or multiple injections of methylprednisolone can effectively reduce the occurrence of postextubation stridor.